Article Text

Download PDFPDF

Latanoprost in port wine stain related paediatric glaucoma
Free
  1. T Ong1,
  2. A Chia1,2,
  3. K K Nischal1,2
  1. 1Department of Ophthalmology, Great Ormond Street Hospital for Children, London, UK
  2. 2Department of Visual Sciences, Institute of Child Health, London, UK
  1. Correspondence to: K K Nischal, Department of Ophthalmology, Great Ormond Street, Hospital for Children, London WC1 3JH, UK; kkn{at}btinternet.com

Abstract

Aim: To evaluate the efficacy of latanoprost (Xalatan) as adjunctive therapy in port wine stain related paediatric glaucoma.

Methods: A retrospective non-randomised study. Patients with previous surgical intervention and medical treatment were included. Measurements were recorded from clinic and/or examination under anaesthetic (EUA) visits. A successful outcome was considered to be patients who required no further intervention following initiation of latanoprost, with stable glaucoma factors as well as drop in intraocular pressure.

Results: 14 patients and 17 eyes were reviewed in total. The mean age of glaucoma diagnosis was 2.59 years (0.1–5.25 years) and of commencing latanoprost was 6.8 years (1.40–12.90 years). Percentage success at 1 month, 3 months, 6 months, and 1 year was 70.6%, 64.7%, 58.9%, and 47.1%, respectively, of eyes treated which translated to 71.4%, 64.2%, 57.1%, and 50% respectively of patients treated.

Conclusions: A trial of latanoprost as adjunctive therapy in patients with port wine stain related glaucoma may temporise the need for surgery; with 50% of patients being controlled at 1 year follow up. Lack of efficacy was detected as early as 1 month following commencement of treatment.

  • latanoprost
  • port wine stain
  • paediatric ophthalmology
View Full Text

Statistics from Altmetric.com

Footnotes

  • The authors have no proprietary or financial interest in any of the products mentioned in this manuscript.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.